Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion
Nakho Chang(Samsung (South Korea)), Hwang Gyun Jeon(Samsung Medical Center)
Cited by 14
Related Papers
Clinicopathologic Characteristics and Prognosis of Xp11.2 Translocation Renal Cell Carcinoma: Multicenter, Propensity Score Matching Analysis
|Clinical Genitourinary Cancer|2017|24